Home/Clinical Trials
CompletedPhase 3CT-2023-104
Berolumab-cvra versus chemotherapy in HER-low breast cancer
Breast cancer · Oncology
Ages 18 years and older2,030 participantsHouston, TX, London, UK +1 more
CompletedPhase 3CT-2025-110
Teravolumab in hidradenitis suppurativa
Hidradenitis suppurativa · Immunology
Ages 18 to 75 years3,000 participantsSeoul, South Korea, Tokyo, Japan +2 more
CompletedPhase 1CT-2024-119
CLV-427 in adults with elevated Lp(a)
Cardiovascular disease · Cardiometabolic
Ages 18 to 80 years50 participantsChicago, IL, Raleigh, NC
CompletedPhase 3CT-2025-130
Solekizumab every-12-weeks dosing study
Plaque psoriasis · Immunology
Ages 18 to 80 years2,680 participantsMadrid, Spain, London, UK +2 more
CompletedPhase 3CT-2023-124
Emzaratinib plus chemotherapy in metastatic lung cancer
Non-small cell lung cancer · Oncology
Ages 18 years and older1,120 participantsToronto, Canada, Raleigh, NC +2 more
CompletedPhase 1CT-2023-128
CLV-419 biomarker study
Heart failure · Cardiometabolic
Ages 18 years and older90 participantsSeoul, South Korea, Toronto, Canada +3 more
Study listings are fictional. Talk with your doctor before joining any clinical trial.